PharmEnable to raise £6M in a round backed by Cambridge Enterprise et al Competitive Intelligence Health services Pharma Investments 01 May 2023 Share:
Round value (USD): 7.49m Round investors: Cambridge Enterprise Jonathan Milner Martlet Capital o2h Ventures Parkwalk Advisors Wren Capital MP Healthcare Venture Management Arrowfield Capital Company: PharmEnable Industry: Competitive Intelligence Health services Pharma
Actimed Therapeutics in a £4.75m series A extension Biotech Health services Pharma Investments 18 August 2023
Actimed Therapeutics announced £5M series A round Biotech Health services Pharma Investments 27 June 2023
BioCorteX secured $5M from Hoxton Ventures and Sofinnova Partners Health services Pharma Software Services Investments 23 March 2023
Veratrak secured £5.3M AI (big data) Competitive Intelligence Pharma Software Services Investments 31 January 2023
PneumoWave in a £7.5M round led by Scottish National Investment Bank Competitive Intelligence Health services Software Services Investments 08 January 2023